HK1210591A1 - 高含量布洛芬鈉顆粒、其製備及其在製備非泡騰固體劑型中的用途 - Google Patents

高含量布洛芬鈉顆粒、其製備及其在製備非泡騰固體劑型中的用途

Info

Publication number
HK1210591A1
HK1210591A1 HK15111340.7A HK15111340A HK1210591A1 HK 1210591 A1 HK1210591 A1 HK 1210591A1 HK 15111340 A HK15111340 A HK 15111340A HK 1210591 A1 HK1210591 A1 HK 1210591A1
Authority
HK
Hong Kong
Prior art keywords
preparation
dosage forms
solid dosage
high content
preparing non
Prior art date
Application number
HK15111340.7A
Other languages
English (en)
Inventor
．布頓
．蘭貝思
．利馬塔
帕特里克．
．胡
Original Assignee
Si Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49841833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1210591(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/714,768 external-priority patent/US9629809B2/en
Application filed by Si Group Inc filed Critical Si Group Inc
Publication of HK1210591A1 publication Critical patent/HK1210591A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK15111340.7A 2012-12-14 2015-11-17 高含量布洛芬鈉顆粒、其製備及其在製備非泡騰固體劑型中的用途 HK1210591A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/714,768 US9629809B2 (en) 2008-07-21 2012-12-14 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
PCT/US2013/072981 WO2014093073A1 (en) 2012-12-14 2013-12-04 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Publications (1)

Publication Number Publication Date
HK1210591A1 true HK1210591A1 (zh) 2016-04-29

Family

ID=49841833

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111340.7A HK1210591A1 (zh) 2012-12-14 2015-11-17 高含量布洛芬鈉顆粒、其製備及其在製備非泡騰固體劑型中的用途

Country Status (9)

Country Link
EP (1) EP2931261A1 (zh)
JP (1) JP6285952B2 (zh)
CN (1) CN104884048B (zh)
BR (1) BR112015013945A8 (zh)
CA (1) CA2894272A1 (zh)
CL (1) CL2015001621A1 (zh)
HK (1) HK1210591A1 (zh)
MX (1) MX2015007571A (zh)
WO (1) WO2014093073A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3675828T (pt) * 2017-08-31 2023-10-09 Novartis Ag Método de preparação de grânulos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
JP4753567B2 (ja) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 付着性の高い薬物を含有する錠剤の製造方法
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
MX2020011961A (es) * 2010-03-24 2022-04-19 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.

Also Published As

Publication number Publication date
JP2016508124A (ja) 2016-03-17
WO2014093073A1 (en) 2014-06-19
EP2931261A1 (en) 2015-10-21
CN104884048A (zh) 2015-09-02
CL2015001621A1 (es) 2015-08-07
JP6285952B2 (ja) 2018-02-28
CA2894272A1 (en) 2014-06-19
CN104884048B (zh) 2018-11-23
BR112015013945A8 (pt) 2019-10-08
BR112015013945A2 (pt) 2017-07-11
MX2015007571A (es) 2016-04-15

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical preparations containing them
HRP20181172T1 (hr) Derivati pirazolpirimidina supstituirani na poziciji 4, te njihova uporaba u proizvodnji lijekova
IL231382A0 (en) History of benzonitriles, their preparation containing them
IL231386A0 (en) Pyrazoloquinolinone derivatives, their preparation and medical use
EP2881395A4 (en) PIPERAZINOTRIZOLE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN THE PREPARATION OF MEDICAMENT
PL2655375T3 (pl) Pochodne pirymidynonu, ich wytwarzanie i ich farmaceutyczne zastosowanie
HK1222563A1 (zh) 藥物組合物、製備及其用途
EP2939662A4 (en) TEMOCOLOMIDE-CONTAINING PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AND METHOD OF MANUFACTURING THEREOF
IL233602A (en) The history of benzamide, their preparation and their pharmaceutical preparations
IL244901A0 (en) Derivatives of aminotetralin and aminoindan, pharmaceutical compositions containing them and their use in therapy
IL237322A0 (en) Solid pharmaceutical preparations containing levothyroxine and their preparation
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL233825A (en) H1-indazole-3-carboxamide compounds, preparations containing them and their use in the preparation of medicines
HK1211570A1 (zh) 茚衍生物、其製備和作為藥物的用途
EP2865666A4 (en) HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE
IL246297A0 (en) History of pyrazine, their preparation and pharmaceutical preparations containing them
HK1204613A1 (zh) 取代的吡喃並和呋喃並喹啉，其製備和藥物用途
HK1210591A1 (zh) 高含量布洛芬鈉顆粒、其製備及其在製備非泡騰固體劑型中的用途
EP2926811A4 (en) ARTEMISCULAR PHARMACEUTICAL COMPOSITION, MANUFACTURE AND USE
EP2844661A4 (en) FUSIONED HETEROCYCLE MORPHINANES, THEIR USE AND PREPARATION THEREOF
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
HK1201179A1 (zh) 抗酸片劑
SG11201406583QA (en) Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spi
GB201112578D0 (en) Pharmaceutical preparation and use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231206